On the Mechanism of the Triphenylphosphine-Azodicarboxylate (Mitsunobu Reaction) Esterification

DOI: 10.1021/ja00318a053

Source and publish data:

Journal of the American Chemical Society p. 1843 - 1845 (1984)

Update date:2022-08-05

Topics:

Authors:

Adam, Waldemar

Narita, Nozomu

Nishizawa, Yoshinori

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja00318a053

Full text of DOI:10.1021/ja00318a053

Products guided by the article

Product name:2-Oxetanone, 3-methyl-4-phenyl-4-(phenylmethyl)-, cis-

Cas No:35947-73-0

R&D Labs maybe for 35947-73-0

New Forms

Contact:+31-24-3886056

Address:Binderskampweg 29 Unit 36
Jinan Jianfeng Chemical Co., Ltd

Contact:0086-531-88110457

Address:sales01(-a-t-)pharmachemm{dot}c+o+m
Shanghai shibo Chemical Co., Ltd

Contact:+86-021-60753516

Address:688 Qiushi Road, Jinshan High-tech Park, Shanghai, China,201512
Shanghai Taibao Pharmaceutical Technology Co., Ltd(expird)

Contact:021-52217366

Address:shanghai
Cangzhou Senary Chemical Science-tech Co., Ltd

Contact:+86-317-3563899, 3563699

Address:168 Jinde Road, Cangzhou, Hebei, China

Relevant to this article

Asymmetric intermolecular C-H functionalization of benzyl silyl ethers mediated by chiral auxiliary-based aryldiazoacetates and chiral dirhodium catalysts

Doi:10.1021/jo051747g
(2005)
Synthesis of quinolone substituted 2-azetidinone derivatives

Doi:10.2298/JSC120617081M
(2013)
Investigations of cascade cyclizations of terpenoid polyalkenes via radical cations. A biomimetic-type synthesis of (±)-3-hydroxy-spongian-16-one

Doi:10.1055/s-2001-15074
(2001)
Regio- and stereoselective α-alkylation of N-terminal amino acid residue of peptides using a pyridoxal model compound with a chiral ansa-structure

Doi:10.1016/S0040-4020(01)00512-9
(2001)
Synthesis and reactivity of indenyl ruthenium(II) complexes containing the labile ligand 1,5-cyclooctadiene (COD): Catalytic activity of [Ru(η⁵-C₉H₇)Cl(COD)]

Doi:10.1021/om010205w
(2001)
Phenoxyphenyl sulfone N-formylhydroxylamines (Retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors

Doi:10.1021/jm0103920
(2002)

Article Doi